Median Technologies

Median Technologies

China - Shanghai
Biotechnology1 H-1B visas (FY2023)

Focus: Imaging Phenomics

Median Technologies is a life sciences company focused on Imaging Phenomics.

OncologyUnknown
Funding Stage
PUBLIC
Open Jobs
9

Pipeline & Clinical Trials

N/A
Clinical Trials (1)
NCT06576232Standalone Observational Study Assessing the Performance of an AI/ML Tech-based SaMD on Chest LDCT Images (REALITY)
N/A
BICR in New Therapeutic Lung Cancer Trials
Lung Cancer
N/A
Clinical Trials (1)
NCT05038826BICR in New Therapeutic Lung Cancer Trials
N/A
N/A
Clinical Trials (1)
NCT06751576Retrospective Clinical Trial Comparing Radiologists' Diagnosis Accuracy in Lung Cancer Screening Population With and Without the Help of an AI/ML Tech-based SaMD
N/A
Clinical Trials (1)
NCT05235490Identification of Image Phenotypes to Predict Recurrence After Resection of Hepatocellular Carcinoma
N/A

Open Jobs (9)

Interview Prep Quick Facts
Founded: 2024
Portfolio: 4 clinical trials
Top TAs: Oncology
H-1B (2023): 1 approval
Publications: 25 in PubMed
Open Roles: 9 active jobs
Therapeutic Area Focus
Oncology
3 pipeline
Marketed
Pipeline

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub